Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: pegfilgrastim|DRUG: carboplatin|DRUG: docetaxel|PROCEDURE: conventional surgery
Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)